Recombinant pseudoadenoviral lactoferrin gene therapy (Ntpharma)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRecombinant pseudoadenoviral lactoferrin gene therapy (Ntpharma)

Drug Alias NameAdeLact

ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Pseudoadenoviral vector

Mechanisms of ActionUpdating

TargetsNot applicable

Therapy Area/IndicationsDrug-Related Side Effects and Adverse Reactions

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesNantpharma Llc

China Registration ClassN/A

Active CompaniesNantpharma Llc

Inactive CompaniesN/A

Active IndicationsDrug-Related Side Effects and Adverse Reactions

Inactive IndicationsN/A

ATC CodeV03AX